Diseases & therapies

We develop and manufacture medicines for patients in three therapeutic areas: haematology, immunotherapy and critical care.


Our medicines replace the missing coagulation factor in patients with bleeding disorders to effectively control or prevent bleeding.


It is the use of immunoglobulin (IgG) medicines to help the body’s own immune system fight infections or immune mediated diseases.

Critical care

Our medicines prevent shock and quickly restore blood volume and clotting function in patients in intensive care and emergency medical situations.